Lidocaína Normon (Lidocaine Hydrochloride Monohydrate)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, preventing sodium influx and halting the generation and propagation of nerve impulses. This interruption stops pain signals from reaching the brain, resulting in localized anesthesia.

The specific dose of Lidocaína Normon is determined by the prescribing clinician based on the intended route (epidural, intra‑articular, or intradermal), patient characteristics, and the clinical situation. No standard dosing is provided here.

Safety data for lidocaine in pregnancy and lactation are limited. It should only be used when clearly needed and after a risk‑benefit assessment by the healthcare provider. Breastfeeding mothers should consult their physician before use.

To request Lidocaína Normon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset and moderate duration, making it suitable for epidural, intra‑articular and intradermal applications. Compared with shorter‑acting agents like procaine, lidocaine offers longer analgesia, while agents such as bupivacaine provide even longer duration but may have higher cardiotoxic risk.

Lidocaína Normon should be stored at controlled room temperature, typically below 25 °C, in its original packaging. Protect the product from direct light, moisture and extreme temperature fluctuations to maintain stability.

The product is supplied as a sterile injectable solution. It is administered by a qualified healthcare professional via epidural catheter, intra‑articular injection into the joint space, or intradermal injection into the skin, following aseptic technique and the prescriber's instructions.

Serious adverse events, although rare, include methemoglobinemia, cardiac arrhythmias and seizures. These reactions require immediate medical attention and may be more likely with high systemic concentrations or in patients with pre‑existing cardiac or metabolic disorders.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid this product. It is also contraindicated in individuals with severe heart block, uncorrected arrhythmias, or certain metabolic conditions that predispose to toxicity.